ScreenerHero
CBAVClinica Baviera, S.A.
BME · ES · Healthcare · Diagnostics & Research · clinicabaviera.com
58.00EUR-0.68%Mkt Cap: 1.02B $P/E: 20.35

Clínica Baviera, S.A., a medical company, provides ophthalmologic medicine services in Spain, Germany, and rest of Europe. The company offers refractive, presbyopia, and cataract surgeries; and oculoplastia, corneal dise…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$226.85BUSDP/E 33.1
DHR
Danaher Corporation
$151.78BUSDP/E 38.6
LONN
Lonza Group Ltd
$46.70BUSDP/E 37.9
NTRA
Natera, Inc.
$46.86BUSD
IDXX
IDEXX Laboratories, Inc.
$44.35BUSDP/E 39.5
A
Agilent Technologies, Inc.
$44.14BUSDP/E 31.4
IQV
IQVIA Holdings Inc
$41.03BUSDP/E 31.0
WAT
Waters Corporation
$40.83BUSDP/E 105.8
ILMN
Illumina, Inc.
$30.95BUSDP/E 38.2
MTD
Mettler-Toledo International, Inc.
$28.55BUSDP/E 32.1
LH
Labcorp Holdings Inc.
$26.80BUSDP/E 27.4
DGX
Quest Diagnostics Incorporated
$26.68BUSDP/E 25.6
GH
Guardant Health, Inc.
$21.92BUSD
MEDP
Medpace Holdings, Inc.
$16.98BUSDP/E 35.8
ERF
Eurofins Scientific SE
$13.64BUSDP/E 25.3
CRL
Charles River Laboratories International, Inc.
$13.84BUSD
RVTY
Revvity Inc. Common Stock
$13.33BUSDP/E 57.4
BIM
bioMerieux S.A.
$9.51BUSDP/E 19.0
QIA
Qiagen N.V.
$8.69BUSDP/E 22.8
TWST
Twist Bioscience Corp.
$8.93BUSD

Key Statistics

Company
Market Cap1.02B $
Enterprise Value1.06B $
Revenue (TTM)348.56M $
Gross Profit291.09M $
Net Income (TTM)45.72M $
Revenue/Share21.78 USD
Last Price58.00 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees2.0K
CountryES
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)20.35
P/E (Forward)33.18
PEG2.70
EV/EBITDA10.94
EV/Revenue3.03
P/S2.92
P/B8.39
EPS (TTM)2.87
EPS (Forward)1.76
52W Range
40.1082% of range62.00
52W High62.00 EUR
52W Low40.10 EUR
Profitability
Gross Margin88.74%
Oper. Margin21.61%
EBITDA Margin27.68%
Profit Margin13.94%
ROE38.24%
ROA16.99%
Growth
Revenue Growth13.30%
Earnings Growth38.70%
Cash Flow & Leverage
Operating CF83.52M $
CapEx (TTM)32.62M $
FCF Margin13.24%
FCF Yield4.53%
Net Debt21.55M $
Net Debt/EBITDA0.22
Balance Sheet
Debt/Equity0.64
Current Ratio0.94
Quick Ratio0.86
Book Value/Sh6.959 EUR
Cash/Share3.170 EUR
Dividends
Fwd Div Rate1.570 EUR
Trail. Div Rate1.570 EUR
Div. Yield2.63%
5Y Avg Yield4.41%
Payout Ratio54.70%
Ex-Div DateJun 10, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.16.03M
Float2.73M
Insiders81.55%
Institutions11.38%
Technical
SMA 5058.10 (-0.2%)
SMA 20052.51 (+10.4%)
Beta0.73
S&P 52W Chg18.16%
Avg Vol (30d)1.41K
Avg Vol (10d)1.43K
Technical Indicators
RSI (14)45.8
MACD0.3916
MACD Signal0.6718
MACD Hist.-0.2802
BB Upper62.29 EUR
BB Middle59.72 EUR
BB Lower57.15 EUR
BB Width8.60%
ATR (14)1.805 EUR
Vol Ratio (20d)2.20x